UNLIMITED TURBO LONG - NOVARTIS N Share Price

Certificat

UINABP

CH1279240167

Market Closed - Swiss Exchange 16:20:00 24/05/2024 BST
0.9 CHF -5.26% Intraday chart for UNLIMITED TURBO LONG - NOVARTIS N
Current month+15.38%
1 month+15.38%
Date Price Change
24/05/24 0.9 -5.26%
23/05/24 0.95 -3.06%
22/05/24 0.98 -2.00%
21/05/24 1 +3.09%
17/05/24 0.97 +3.19%

Delayed Quote Swiss Exchange

Last update May 24, 2024 at 04:20 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer BNP Paribas BNP Paribas
UINABP
ISINCH1279240167
Date issued 19/10/2023
Strike 74.3 CHF
Maturity Unlimited
Parity 20 : 1
Emission price- CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 1 CHF
Lowest since issue 0.49 CHF
Spread 0.01 CHF
Spread %1.11%

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
101.5 USD
Average target price
108 USD
Spread / Average Target
+6.50%
Consensus
  1. Stock Market
  2. Certificates
  3. UINABP Certificat